Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study

We analyzed the treatment responses, toxicities, and survival outcomes of patients with relapsed or refractory multiple myeloma who received daily thalidomide, cyclophosphamide, and dexamethasone (CTD) or daily thalidomide, melphalan, and prednisolone (MTP) at 17 medical centers in Korea. Three‐hund...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Kwon, Jihyun, Min, Chang‐Ki, Kim, Kihyun, Han, Jae‐joon, Moon, Joon Ho, Kang, Hye Jin, Eom, Hyeon‐Seok, Kim, Min Kyoung, Kim, Hyo Jung, Yoon, Dok Hyun, Lee, Jeong‐Ok, Lee, Won Sik, Lee, Jae Hoon, Lee, Je‐Jung, Choi, Yoon‐seok, Kim, Sung hyun, Yoon, Sung‐soo
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5269709/
https://ncbi.nlm.nih.gov/pubmed/27905203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.970
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi